title: Fulminant neuroleptic malignant syndrome after perioperative withdrawal of antiParkinsonian medication.
abstract: Neuroleptic malignant syndrome is a rare complication when using neuroleptic drugs. We report the case of a patient with severe Parkinson's disease who developed neuroleptic malignant syndrome after withdrawal of his antiParkinsonian medication for elective coronary artery bypass grafting. Sodium dantrolene may be a therapeutic option in severe cases.
authors.affiliation: Department of Anaesthesia, University of Basel/Kantonsspital, CH-4031 Basel, Switzerland. Stotzm@hotmail.com
authors.forename: M
authors.initials: M
authors.lastname: Stotz
authors.forename: D
authors.initials: D
authors.lastname: Thümmler
authors.forename: M
authors.initials: M
authors.lastname: Schürch
authors.forename: J-C
authors.initials: JC
authors.lastname: Renggli
authors.forename: A
authors.initials: A
authors.lastname: Urwyler
authors.forename: H
authors.initials: H
authors.lastname: Pargger
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects*; D001026:Coronary Artery Bypass; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D011183:Postoperative Complications / Q000175:diagnosis*; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis*
chemical_list: D000978:Antiparkinson Agents